A detailed history of Bank Of America Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Bank Of America Corp holds 213,654 shares of BNTX stock, worth $24.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
213,654
Previous 91,988 132.26%
Holding current value
$24.6 Million
Previous $7.39 Million 243.28%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.36 - $124.66 $9.53 Million - $15.2 Million
121,666 Added 132.26%
213,654 $25.4 Million
Q2 2024

Aug 14, 2024

SELL
$80.36 - $102.87 $9.29 Million - $11.9 Million
-115,643 Reduced 55.7%
91,988 $7.39 Million
Q1 2024

May 15, 2024

BUY
$88.96 - $112.35 $5.87 Million - $7.41 Million
65,947 Added 46.55%
207,631 $19.2 Million
Q4 2023

Feb 14, 2024

BUY
$90.91 - $112.75 $1.2 Million - $1.49 Million
13,229 Added 10.3%
141,684 $15 Million
Q2 2023

Aug 14, 2023

SELL
$102.58 - $129.66 $1.64 Million - $2.07 Million
-15,988 Reduced 11.07%
128,455 $13.9 Million
Q1 2023

May 12, 2023

BUY
$122.57 - $153.67 $5.18 Million - $6.49 Million
42,234 Added 41.32%
144,443 $18 Million
Q4 2022

Feb 10, 2023

BUY
$118.43 - $186.05 $1.01 Million - $1.59 Million
8,522 Added 9.1%
102,209 $15.4 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $2.86 Million - $4.11 Million
22,432 Added 31.48%
93,687 $12.6 Million
Q2 2022

Aug 12, 2022

SELL
$123.25 - $186.24 $4.14 Million - $6.26 Million
-33,600 Reduced 32.04%
71,255 $10.6 Million
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $2.53 Million - $4.64 Million
20,029 Added 23.61%
104,855 $17.9 Million
Q4 2021

Feb 08, 2022

BUY
$216.64 - $362.52 $4.61 Million - $7.71 Million
21,272 Added 33.47%
84,826 $21.9 Million
Q3 2021

Nov 15, 2021

SELL
$205.93 - $447.23 $9.63 Million - $20.9 Million
-46,769 Reduced 42.39%
63,554 $17.4 Million
Q2 2021

Sep 13, 2021

BUY
$113.32 - $241.49 $12.5 Million - $26.6 Million
110,323 New
110,323 $24.7 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.